
Hepatitis testing can save lives
Each year, viral hepatitis kills more people than HIV/AIDS and malaria combined. Worldwide, more than 350 million people are living with hepatitis. Prompt detection and treatment of viral hepatitis can help stop the spread and save lives.
Did You Know?
Nobel-prize winning scientist Dr. Baruch Blumberg discovered the hepatitis B virus (HBV), and created both a diagnostic test and vaccine. Now, World Hepatitis Day is celebrated each year on July 28, Dr. Blumberg’s birthday.
- 1.3 million deaths from hepatitis B and C each year Worldwide, 290 million people with viral hepatitis don’t know they have the disease
- 90% of people living with hepatitis B that don’t know that they have the disease
- Hepatitis C is curable
- Hepatitis B is treatable and can be managed, but less than 1% of patients with HBV are treated
We can’t wait
The theme of World Hepatitis Day 2022 is “Hepatitis Can’t Wait.” According to the WHO, a person dies every 30 seconds from a hepatitis-related illness. We know that expanded access to testing and treatment are key to saving lives. That’s why the CDC recommends one-time hepatitis C testing for all adults, and additional screening in pregnant individuals and people with other risk factors.

The fact that millions of cases of viral hepatitis are undiagnosed is what makes this disease one of our most important global health opportunities.
Davide Manissero MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN
From the field
Test your knowledge
In just the last few years we’ve seen great advances in our ability to detect, treat and in some cases cure hepatitis. That is tremendously exciting.
Now is our chance to eradicate viral hepatitis, and put an end to all of the suffering it causes people around the world.
Davide Manissero MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN
Contact us
1. World Hepatitis Alliance. (2021) What is Viral Hepatitis? https://www.worldhepatitisalliance.org/what-viral-hepatitis-0
2. Centers for Disease Control and Prevention. (2020) Hepatitis C. https://www.cdc.gov/hepatitis/hcv/index.htm
Product availability may vary by country specific regulatory requirements and approvals. Contact your country representative or visit www.neumodx.com/client-resources for further details.
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN/NeuMoDx kit handbook or user operator manual. QIAGEN handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor) or www.neumodx.com/client-resources.